- Previous Close
205.03 - Open
204.81 - Bid 208.34 x 100
- Ask 208.68 x 100
- Day's Range
204.77 - 209.31 - 52 Week Range
186.01 - 335.40 - Volume
841,295 - Avg. Volume
774,381 - Market Cap (intraday)
15.58B - Beta (5Y Monthly) 1.64
- PE Ratio (TTM)
35.59 - EPS (TTM)
5.86 - Earnings Date Jan 29, 2025 - Feb 3, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
258.34
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
www.aligntech.com21,610
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ALGN
View MorePerformance Overview: ALGN
Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALGN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALGN
View MoreValuation Measures
Market Cap
15.58B
Enterprise Value
14.63B
Trailing P/E
35.59
Forward P/E
20.37
PEG Ratio (5yr expected)
1.22
Price/Sales (ttm)
3.97
Price/Book (mrq)
3.95
Enterprise Value/Revenue
3.70
Enterprise Value/EBITDA
21.54
Financial Highlights
Profitability and Income Statement
Profit Margin
11.15%
Return on Assets (ttm)
6.70%
Return on Equity (ttm)
11.40%
Revenue (ttm)
3.96B
Net Income Avi to Common (ttm)
441.57M
Diluted EPS (ttm)
5.86
Balance Sheet and Cash Flow
Total Cash (mrq)
1.04B
Total Debt/Equity (mrq)
2.44%
Levered Free Cash Flow (ttm)
394.52M
Research Analysis: ALGN
View MoreCompany Insights: ALGN
ALGN does not have Company Insights
Research Reports: ALGN
View MoreRaising target price to $223.00
ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $223.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetAlign Earnings: Tough End-Market Slows Growth but Cheap Shares Could Leave Patient Investors Smiling
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
RatingPrice TargetLowering target price to $221.00
ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $221.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetLowering target price to $230.00
ALIGN TECHNOLOGY INC has an Investment Rating of HOLD; a target price of $230.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target